Showing 1 - 10 of 4,404
This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era …. The WTO's TRIPS Agreement (TRIPS) makes it obligatory for WTO members − except least-developed country members (LDCs) - to … to be compliant with this provision of TRIPS by 2005. This study investigates two questions in this context: (1) How does …
Persistent link: https://www.econbiz.de/10011992779
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted...
Persistent link: https://www.econbiz.de/10011509446
Persistent link: https://www.econbiz.de/10011925529
Persistent link: https://www.econbiz.de/10010252982
Persistent link: https://www.econbiz.de/10014318667
Persistent link: https://www.econbiz.de/10010228321
Persistent link: https://www.econbiz.de/10011665495
The paper addresses the question of whether expanded and strengthened protection of intellectual property (IP) fosters technology transfer to developing countries. Cross-sectional analysis of a representative sample of firms operating in 42 developing economies indicates that going from no IP...
Persistent link: https://www.econbiz.de/10011703236
Persistent link: https://www.econbiz.de/10012173379
Persistent link: https://www.econbiz.de/10015076909